UNSPSC 51386008: Fenclozic acid

This classification denotes a cyclooxygenase inhibitor with the molecular formula C11H8ClNO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58SRQ4DV53, chemically known as 4-thiazoleacetic acid, 2-(p-chlorophenyl)- but generally known as fenclozic acid, which bears US NIH Compound Identifier 28858. European Medicines Agency schedules Fenclozic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07553MIG.

UNSPSC 51386008 Fenclozic acid is a Commodity code that shows minimal alignment with current state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health support, not fenclozic acid as the code nominally describes. The mismatch suggests either a data-entry error in the county's procurement system or a misclassification of the opportunity within UNSPSC taxonomy. State and local governments do not appear to be actively soliciting fenclozic acid through public notice processes.

Seminole County posted the naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2023 (a date incongruent with the posting date, indicating a data error in the source). The procurement calls for annual delivery of 1,900 units of naloxone and 800 safe drug deactivation systems via quarterly shipments to the Seminole County Community Health Building in Sanford, Florida, with vendors bearing all shipping costs. The contract includes a two-year initial term with a one-year renewal option, subject to a three-month probationary period and potential FEMA funding with associated federal compliance requirements. Without additional recent opportunities correctly tagged to this Commodity code, no meaningful geographic spread or issuing-body pattern can be identified.